Dec 21, 2021 4:01 pm EST BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
Dec 21, 2021 6:00 am EST BioRestorative Therapies CEO Interviewing Live on the James Hicks NewMedia Show
Dec 2, 2021 6:00 am EST BioRestorative Therapies Announces Filing of Ten Patent Applications Related to its BRTX-100 Program
Nov 4, 2021 9:21 pm EDT BioRestorative Therapies Prices $23 Million Public Offering and Uplisting to the Nasdaq Capital Market
Oct 26, 2021 4:05 pm EDT BioRestorative Therapies Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq
Oct 26, 2021 8:00 am EDT BioRestorative Therapies Announces Nomination of Two New Members to the Board of Directors